Cytokinetics has revealed the results from a phase 3 trial of its hypertrophic cardiomyopathy (HCM) drug aficamten that it hopes will allow it to compete with Bristol-Myers Squibb’s first-to-market ...
This neo-Gothic cathedral may catch your eye with its enormous spires and you'll hear it referred to by many (similar) names, including Catedral da Sé, Catedral Metropolitana and Catedral da Sé de São ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results